These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 31835371)

  • 21. Resveratrol for cancer therapy: Challenges and future perspectives.
    Ren B; Kwah MX; Liu C; Ma Z; Shanmugam MK; Ding L; Xiang X; Ho PC; Wang L; Ong PS; Goh BC
    Cancer Lett; 2021 Sep; 515():63-72. PubMed ID: 34052324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resveratrol in human cancer chemoprevention--choosing the 'right' dose.
    Scott E; Steward WP; Gescher AJ; Brown K
    Mol Nutr Food Res; 2012 Jan; 56(1):7-13. PubMed ID: 22218912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resveratrol induces autophagy-dependent apoptosis in HL-60 cells.
    Fan Y; Chiu JF; Liu J; Deng Y; Xu C; Zhang J; Li G
    BMC Cancer; 2018 May; 18(1):581. PubMed ID: 29788929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resveratrol and derivatives for the prevention and treatment of cancer.
    Fulda S
    Drug Discov Today; 2010 Sep; 15(17-18):757-65. PubMed ID: 20692359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
    Aggarwal BB; Bhardwaj A; Aggarwal RS; Seeram NP; Shishodia S; Takada Y
    Anticancer Res; 2004; 24(5A):2783-840. PubMed ID: 15517885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of cell death and survival by resveratrol: implications for cancer therapy.
    Fulda S
    Anticancer Agents Med Chem; 2012 Oct; 12(8):874-9. PubMed ID: 22292764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resveratrol represses estrogen-induced mammary carcinogenesis through NRF2-UGT1A8-estrogen metabolic axis activation.
    Zhou X; Zhao Y; Wang J; Wang X; Chen C; Yin D; Zhao F; Yin J; Guo M; Zhang L; Du L; Zhang B; Yin X
    Biochem Pharmacol; 2018 Sep; 155():252-263. PubMed ID: 30009768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resveratrol derivatives from Commiphora africana (A. Rich.) Endl. display cytotoxicity and selectivity against several human cancer cell lines.
    Segun PA; Ogbole OO; Ismail FMD; Nahar L; Evans AR; Ajaiyeoba EO; Sarker SD
    Phytother Res; 2019 Jan; 33(1):159-166. PubMed ID: 30346066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resveratrol and cancer: a review.
    Savouret JF; Quesne M
    Biomed Pharmacother; 2002 Mar; 56(2):84-7. PubMed ID: 12000139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review Deciphering the Anticancer Efficacy of Resveratrol and their Associated Mechanisms in Human Carcinoma.
    Arif M; Pandey P; Khan F
    Endocr Metab Immune Disord Drug Targets; 2024; 24(9):1015-1026. PubMed ID: 37929735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implications of Resveratrol on Glucose Uptake and Metabolism.
    León D; Uribe E; Zambrano A; Salas M
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28272357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Walking a Tightrope: A Perspective of Resveratrol Effects on Breast Cancer.
    Bartolacci C; Andreani C; Amici A; Marchini C
    Curr Protein Pept Sci; 2018; 19(3):311-322. PubMed ID: 28079008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resveratrol and its oligomers: modulation of sphingolipid metabolism and signaling in disease.
    Lim KG; Gray AI; Anthony NG; Mackay SP; Pyne S; Pyne NJ
    Arch Toxicol; 2014 Dec; 88(12):2213-32. PubMed ID: 25344023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer.
    Delmas D; Lançon A; Colin D; Jannin B; Latruffe N
    Curr Drug Targets; 2006 Apr; 7(4):423-42. PubMed ID: 16611030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The basis for the chemopreventive action of resveratrol.
    Roemer K; Mahyar-Roemer M
    Drugs Today (Barc); 2002 Aug; 38(8):571-80. PubMed ID: 12582422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resveratrol--a prostate cancer chemopreventive agent?
    Ratan HL; Steward WP; Gescher AJ; Mellon JK
    Urol Oncol; 2002; 7(6):223-7. PubMed ID: 12504842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural dimers of coumarin, chalcones, and resveratrol and the link between structure and pharmacology.
    Menezes JCJMDS; Diederich MF
    Eur J Med Chem; 2019 Nov; 182():111637. PubMed ID: 31494471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resveratrol and cancer treatment: updates.
    Jiang Z; Chen K; Cheng L; Yan B; Qian W; Cao J; Li J; Wu E; Ma Q; Yang W
    Ann N Y Acad Sci; 2017 Sep; 1403(1):59-69. PubMed ID: 28945938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ascorbic acid in cancer chemoprevention: translational perspectives and efficacy.
    Ullah MF; Bhat SH; Hussain E; Abu-Duhier F; Ahmad A; Hadi SM
    Curr Drug Targets; 2012 Dec; 13(14):1757-71. PubMed ID: 23140287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resveratrol, a natural chemopreventive agent against degenerative diseases.
    Ignatowicz E; Baer-Dubowska W
    Pol J Pharmacol; 2001; 53(6):557-69. PubMed ID: 11985329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.